Literature DB >> 27277399

Leucine-Rich Amelogenin Peptide (LRAP) Uptake by Cementoblast Requires Flotillin-1 Mediated Endocytosis.

Luciane Martins1, Adriana Franco Paes Leme2, Kamila Rosamilia Kantovitz3, Em Nome de Luciane Martins4, Enilson Antonio Sallum1, Márcio Zaffalon Casati1, Francisco Humberto Nociti1.   

Abstract

Basic, pre-clinical, and clinical studies have documented the potential of amelogenin, and its variants, to affect cell response and tissue regeneration. However, the mechanisms are unclear. Thus, the aim of the present study was to identify, in cementoblasts, novel binding partners for an alternatively spliced amelogenin form (Leucine-Rich Amelogenin Peptide-LRAP), which is supposed to act as a signaling molecule in epithelial-mesenchymal interactions. LRAP-binding protein complexes from immortalized murine cementoblasts (OCCM-30) were achieved by capture affinity assay (GST pull down) and proteins present in these complexes were identified by mass spectrometry and immunoblotting. Flotillin-1, which functions as a platform for signal transduction, vesicle trafficking, endocytosis, and exocytosis, was identified and confirmed by co-precipitation and co-localization assays as a protein-binding partner for LRAP in OCCM-30 cells. In addition, we found that exogenously added GST-LRAP recombinant protein was internalized by OCCM-30 cells, predominantly localized in the perinuclear region and, that inhibition of flotillin1-dependent functions by small interference RNA (siRNA) methodology significantly affected LRAP uptake and its biological properties on OCCM-30 cells, including LRAP effect on the expression of genes encoding osteocalcin (Ocn), bone sialoprotein (Bsp), and runt-related transcription factor 2 (RunX2). In conclusion, LRAP uptake by cementoblast involves flotillin-assisted endocytosis, which suggests an involvement of LRAP in lipid-raft-dependent signaling pathways which are mediated by flotillin-1. J. Cell. Physiol. 232: 556-565, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27277399     DOI: 10.1002/jcp.25453

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

Review 1.  Flotillin membrane domains in cancer.

Authors:  Cécile Gauthier-Rouvière; Stéphane Bodin; Franck Comunale; Damien Planchon
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

2.  Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.

Authors:  Karen Yotsumoto; Terukazu Sanui; Urara Tanaka; Hiroaki Yamato; Rehab Alshargabi; Takanori Shinjo; Yuki Nakao; Yukari Watanabe; Chikako Hayashi; Takaharu Taketomi; Takao Fukuda; Fusanori Nishimura
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

Review 3.  Flotillins: At the Intersection of Protein S-Palmitoylation and Lipid-Mediated Signaling.

Authors:  Katarzyna Kwiatkowska; Orest V Matveichuk; Jan Fronk; Anna Ciesielska
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.